| Tag | Content |
|---|
EnhancerAtlas ID | HS109-15003 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr3:15847090-15847960 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr3:15847615-15847633 | TGAAAGAAGGAAGGTATG | + | 6.07 | | FOXF2 | MA0030.1 | chr3:15847308-15847322 | AATGTTTACCTTTA | - | 6.27 | | MEF2C | MA0497.1 | chr3:15847527-15847542 | AGCTATTTTTAAATT | - | 6.06 | | RFX1 | MA0509.2 | chr3:15847291-15847307 | AGTTGCTATGGTTACA | + | 6.05 | | RFX1 | MA0509.2 | chr3:15847291-15847307 | AGTTGCTATGGTTACA | - | 6.05 | | RFX2 | MA0600.2 | chr3:15847291-15847307 | AGTTGCTATGGTTACA | + | 6.11 | | RFX2 | MA0600.2 | chr3:15847291-15847307 | AGTTGCTATGGTTACA | - | 6.14 |
|
| | Number of super-enhancer constituents: 11 | ID | Coordinate | Tissue/cell |
| SE_02838 | chr3:15847081-15848103 | Astrocytes | | SE_12861 | chr3:15845772-15848342 | CD34_Primary_RO01480 | | SE_13323 | chr3:15844928-15849098 | CD34_Primary_RO01536 | | SE_14051 | chr3:15845292-15848580 | CD34_Primary_RO01549 | | SE_38632 | chr3:15846337-15848597 | HUVEC | | SE_44498 | chr3:15846605-15848104 | NHDF-Ad | | SE_45074 | chr3:15846056-15848171 | NHLF | | SE_45816 | chr3:15845860-15849011 | Osteoblasts | | SE_52111 | chr3:15846983-15847606 | Skeletal_Muscle_Myoblast | | SE_56307 | chr3:15846429-15847880 | u87 | | SE_63925 | chr3:15846969-15847606 | HSMM |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I015803 | chr3 | 15845146 | 15848878 |
|
Enhancer Sequence | AATTTAGCCC TCATATTAAA ATCAGTTGAG TGCAAAATTT TTATTTTAAA CAGGCTGAAT 60
TTTGCCCTTC TTAAAAAAAG ATTGAGGAAA GATTATGTGC AATTCATTCT GGTTTTTACA 120
ATGTGGTGAT GCCAGAGTAA ATGTAGTATG AAGTTAATGC ACTTTAAAAG CTGAAGGGAG 180
AAAATTTTCA GTTTTAAAAT AAGTTGCTAT GGTTACAAAA TGTTTACCTT TATAAGCAAT 240
AATTATGTGA GATGTCCAAG GAATTCCCGA AAGTACAGTA AGATCAGTAT CTGAAGTGTA 300
CATTCGTTAT TTCACAAACA AACTGAACCC AACTGCATAC ATCACTTCCG TTTCAAAGTG 360
GCTATCGTTT GGGAAATACT AAAAAAAAAA TGATTCATGT CTTTCTGAAC CATATTGGAG 420
ACAAAAATAC TGACCATAGC TATTTTTAAA TTCAAGTAAT GACTCAGAGA GTTTTAGTTC 480
CTTTTATCAA AGAGTGCTGT AATTTTACAT AGCACCTTCT ATTGTTGAAA GAAGGAAGGT 540
ATGTTTGTAA TGTGTCTCAG GTGTGGAGTT TCTTTTATAC ATAAATTTTC ACGCCTTCGA 600
TAAACTTTTA AAAAGCCATG CTTGTAACAA TGTTAATTCA GAGTAAAACG ATGTCAACTC 660
CTTTAGCTGT AGACAATTTT GAACTTCTTA AATGGGAAGA AGAGGCCCCT ATAAGAATTG 720
ATAATTAGCC CATTCCTAAC TAGGTTGTTA AATCCGCTAT CAGTTACTGT ATTGTAGAAA 780
TTTTTTGTGT GTCTGTGTTT TACATTTAGA ACATTCAGTT TTGTAAGACT ACTTATAAAA 840
CTTTCAACCC CATATAGCTG ATCTTAAAAT 870
|
